FDA
approval
· 2020-07-07
FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) submitted by Cumberland Pharmaceuticals Inc. The action updates the labeling and/…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VIBATIV (TELAVANCIN HYDROCHLORIDE)